Related Experiment Video

Updated: May 26, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Epigenetic regulation and colorectal cancer

Nagahide Matsubara1

  • 1Department of Surgery, Hyogo College of Medicine, Hyogo, Japan. nagamb@hyo-med.ac.jp

Diseases of the Colon and Rectum
|December 14, 2011
PubMed

Insights

Epigenetic silencing, including DNA methylation, inactivates tumor suppressor genes in colorectal cancer. Understanding these epigenetic changes offers new biomarkers for diagnosis and treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Epigenetic silencing of tumor suppressor genes is crucial in carcinogenesis.
  • Colorectal cancer serves as a model for studying epigenetic mechanisms in tumorigenesis.
  • Genetic alterations in colorectal cancer are well-documented, providing a foundation for epigenetic research.

Purpose of the Study:

  • To elucidate the role of epigenetic mechanisms, specifically DNA methylation and histone modification, in colorectal carcinogenesis.
  • To investigate the early events of DNA methylation in cancer-related gene promoters during tumorigenesis.
  • To identify potential epigenetic biomarkers for colorectal cancer diagnosis, risk assessment, and treatment.

Main Methods:

  • Analysis of DNA methylation patterns in colorectal cancer tissues.
  • Investigation of histone modification profiles associated with gene silencing.
  • Correlation of epigenetic alterations with tumor progression and clinical outcomes.

Main Results:

  • Epigenetic silencing is a key mechanism for tumor suppressor gene inactivation in colorectal cancer.
  • DNA methylation and histone modification form a complex network maintaining gene silencing.
  • Promoter DNA methylation in cancer-related genes is an early event in tumorigenesis, varying across colorectal cancer types.

Conclusions:

  • Epigenetic alterations are fundamental to colorectal cancer development.
  • Early DNA methylation events are significant in colorectal tumorigenesis.
  • Advances in understanding epigenetic mechanisms can lead to novel biomarkers for improved patient care in colorectal cancer.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...